Ali Ghandi
Papers
1
Total Citations
6
H-Index
1
About
Ali Ghandi is a clinical researcher whose work focuses on improving outcomes in breast cancer radiotherapy, particularly through the reduction of treatment-related toxicities. His key research areas include accelerated partial breast irradiation (APBI), skin-sparing techniques, and the use of injectable spacers to protect healthy tissue during radiation therapy. Ghandi’s major contribution is the development and clinical testing of a hyaluronic acid spacer injection designed to reduce skin toxicity in brachytherapy-based APBI. His 2018 study protocol for a randomized controlled trial on this approach, which has garnered 6 citations, lays the groundwork for a novel method to lower skin dose—a primary risk factor for toxicity—while maintaining effective tumor control. This work addresses a critical challenge in breast cancer treatment: balancing efficacy with quality of life. By proposing a minimally invasive intervention to protect the skin, Ghandi’s research has the potential to expand the eligibility and tolerability of APBI for early-stage breast cancer patients. His contributions are particularly notable for their translational focus, bridging preclinical insights with practical clinical applications to enhance patient care.
Research Focus
Key Achievements
Top Papers
- 1